INSR Gene Diabetes Mellitus Insulin-Resistant with Acanthosis Nigricans Genetic Test
The INSR gene is associated with a condition called diabetes mellitus, insulin-resistant with acanthosis nigricans. This genetic test, known as Next-Generation Sequencing (NGS), is used to identify mutations or variations in the INSR gene that may be causing or contributing to the development of this condition.
Diabetes mellitus is a chronic metabolic disorder characterized by high blood sugar levels. Insulin resistance refers to the body’s decreased ability to respond to insulin, a hormone that helps regulate blood sugar levels. Acanthosis nigricans is a skin condition characterized by dark, thickened patches of skin, commonly found in body folds and creases.
NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes, including the INSR gene. By sequencing the entire gene or specific regions of interest, NGS can detect variations or mutations that may be associated with the development of diabetes mellitus, insulin resistance, and acanthosis nigricans.
The results of the NGS genetic test can provide valuable information for diagnosis, prognosis, and treatment decisions. It can help healthcare providers understand the underlying genetic cause of the condition and tailor treatment plans accordingly. Additionally, genetic testing can also be useful for family members who may be at risk of inheriting the condition, as it can inform them about their own genetic predisposition.
It is important to note that genetic testing is typically done in conjunction with other clinical evaluations and tests to provide a comprehensive understanding of the condition. Genetic counselors or healthcare providers can provide more information about the specific implications and limitations of the NGS genetic test for INSR gene-related diabetes mellitus, insulin resistance, and acanthosis nigricans.
Test Details
- Test Name: INSR Gene Diabetes Mellitus Insulin-Resistant with Acanthosis Nigricans Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for INSR Gene Diabetes Mellitus, Insulin-Resistant with Acanthosis Nigricans NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Diabetes Mellitus, Insulin-Resistant with Acanthosis Nigricans.
| Test Name | INSR Gene Diabetes mellitus insulin-resistant with acanthosis nigricans Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for INSR Gene Diabetes mellitus, insulin-resistant with acanthosis nigricans NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Diabetes mellitus, insulin-resistant with acanthosis nigricans |
| Test Details |
The INSR gene is associated with a condition called diabetes mellitus, insulin-resistant with acanthosis nigricans. This genetic test, known as Next-Generation Sequencing (NGS), is used to identify mutations or variations in the INSR gene that may be causing or contributing to the development of this condition. Diabetes mellitus is a chronic metabolic disorder characterized by high blood sugar levels. Insulin resistance refers to the body’s decreased ability to respond to insulin, a hormone that helps regulate blood sugar levels. Acanthosis nigricans is a skin condition characterized by dark, thickened patches of skin, commonly found in body folds and creases. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes, including the INSR gene. By sequencing the entire gene or specific regions of interest, NGS can detect variations or mutations that may be associated with the development of diabetes mellitus, insulin resistance, and acanthosis nigricans. The results of the NGS genetic test can provide valuable information for diagnosis, prognosis, and treatment decisions. It can help healthcare providers understand the underlying genetic cause of the condition and tailor treatment plans accordingly. Additionally, genetic testing can also be useful for family members who may be at risk of inheriting the condition, as it can inform them about their own genetic predisposition. It is important to note that genetic testing is typically done in conjunction with other clinical evaluations and tests to provide a comprehensive understanding of the condition. Genetic counselors or healthcare providers can provide more information about the specific implications and limitations of the NGS genetic test for INSR gene-related diabetes mellitus, insulin resistance, and acanthosis nigricans. |
